Léim ar aghaidh chuig an bpríomhábhar
Gnáthamharc

Genetically Modified Organisms.

Dáil Éireann Debate, Thursday - 28 October 2004

Thursday, 28 October 2004

Ceisteanna (110, 111)

Mary Upton

Ceist:

109 Dr. Upton asked the Tánaiste and Minister for Health and Children if she has had discussions with the Office of Consumer Affairs and the Food Safety Authority of Ireland concerning prosecuting and fining companies that falsely label food products as being free of genetically modified ingredients; if her attention has been drawn to claims from the FSAI that several companies have labelled products as genetically modified free in spite of the fact that FSAI tests indicated that genetically modified ingredients were present in the foods; and if she will make a statement on the matter. [20092/04]

Amharc ar fhreagra

Freagraí scríofa

The Food Safety Authority of Ireland, FSAI, is the competent authority in Ireland for the enforcement of EU legislation regarding food derived from genetically modified organisms, GMOs, generally referred to as GM food. This includes the enforcement of food labelling provisions for which the FSAI carries out checks on the market place for compliance.

Ireland, in common with other member states and as required by EU rules, applies EU legislation on GM foods. EU legislation on GM foods is in the form of EU regulations which are directly applicable to and binding on each member state. My Department is currently working on introducing measures into national legislation which will allow for enforcement measures including penalties in the case of non-compliance with the recently adopted EU regulations.

The regulation on GM food and feed — EC No. 1829/2003 — shifts the basis for labelling from presence-detection of genetically modified DNA or protein, to apply to any products produced or derived from GM material, regardless of the presence-detectability of genetically modified material. In order to ensure the practicability and feasibility of this regulation, a labelling threshold applies to foods containing material which contains, consists of or is produced from GMOs. The threshold applies to the adventitious and technically unavoidable presence of authorised genetically modified material in a proportion no higher than 0.9 % of the food ingredients considered individually or food consisting of a single ingredient.

This threshold recognises that despite the fact that some operators avoid using GMOs, such material may gain access to conventional food and feed in minute traces as a result of adventitious or technically unavoidable co-mingling during production, cultivation, harvest, transport, storage or processing.

The FSAI has in the past identified certain products bearing labels identifying the product as GM-free when in fact a level of GM was present, albeit lower than the 0.9% threshold. Currently the FSAI is specifically examining foods carrying GM-free type labels with a view to the authenticity of such labels. Article 2 of Directive 2000/13/EC of the European Parliament and of the Council of 20 March 2000 on the approximation of the laws of the member states relating to the labelling, presentation and advertising of foodstuffs, provides that labelling must not mislead the purchaser as to the characteristics of the foodstuff and in particular, as to its nature, identity, properties, composition, method of production and manufacturing. The use of GM-free type labelling is voluntary and legal when no GM ingredients are present in a food where GM ingredients could be found. However, it is not legal under the general labelling directive to label something as GM-free when there is actually no GM variety of that food or ingredient available as this could mislead the purchaser. For example, labelling milk as GM free is not legal since there is no GM milk available. The views of the FSAI on GM-free labels and the actions taken to address the problem have received the support of many other member states and the European Commission at Standing Committee level.

The FSAI is actively engaging with retailers to address the problem of foods inaccurately labelled as GM-free, an approach that is also being used in addressing other labelling inaccuracies. This approach places the onus on the retailer to remove specific affected batches from the shelves and to liaise with their suppliers in order to either rectify any labelling inaccuracies or have that product line restricted or discontinued. In this way inaccurate labelling can be more quickly addressed without the immediate need for legal action which would tie up scarce resources for long periods.

The FSAI is constantly engaged in educating industry as to the implications of the recent changes in EU regulations on GMOs, including the issue of labelling. To this end, and in conjunction with Departments and industry organisations, the FSAI is formulating a guidance note for industry which will highlight the impact of the legislation with regard to GMOs and all derived products.

It must be stressed that no product consisting of, containing or derived from GMOs can be authorised for marketing without first having undergone the appropriate safety assessment. Consequently, I am satisfied that appropriate arrangements are in place to ensure the safety of authorised GM foods, or foods containing GM ingredients placed on the market in Ireland. Consumer safety and consumer choice are paramount in the approach taken to GM foods, as reflected in the extent of the legislation developed to deal with this sensitive area. Government policy on GM foods is based on the advice that no credible evidence has yet been provided to show that GM foods pose a risk to human health.

Mary Upton

Ceist:

110 Dr. Upton asked the Tánaiste and Minister for Health and Children her views on the European Commission decision to authorise the marketing of a genetically modified form of sweetcorn, thus ending the six-year ban on new genetically modified foods in the EU; her further views on the consequences of this decision for the marketing of more genetically modified foods throughout the EU; and if she will make a statement on the matter. [20091/04]

Amharc ar fhreagra

On 19 May 2004, the European Commission authorised the placing on the market of sweetcorn from genetically modified maize line Bt11. The significance of this decision is that granting the approval in this case ended an almost six year de facto moratorium during which no new GM events, be they food, feed or the deliberate release of crops, were approved within the EU.

This decision taken by the Commission was the result of the decision making process known as comitology. In order to grant Community authorisation, a draft Commission decision was submitted to the Standing Committee on Food Chain and Animal Health on 8 December 2003. However the necessary qualified majority was not achieved. Under comitology rules it was then necessary for the Commission to put forward a proposal to Council for a vote on the application. If Council were to fail to come to a decision or fail to act on the proposal within three months of having received it the proposal would then revert back to the Commission for a decision. The proposal was put on the agenda of the Agriculture Council on April 26 in order for Council to meet its obligation to act before the end of April 2004. However, the Agriculture Council did not achieve a qualified majority either for or against the proposal. Consequently, on 19 May 2004, the European Commission authorised the placing on the market of sweet corn from genetically modified maize line Bt11.

Ireland, represented by the Department of Health and Children at the Standing Committee on the Food Chain and Animal Health and by the Department of Agriculture and Food at the Agriculture Council, supported this proposal. Ireland's decision to support the proposal was taken after consultation with the Food Safety Authority of Ireland, FSAI, and was based on the scientific risk assessment undertaken on this product, initially by the Netherlands' food assessment body and subsequently by the EU Scientific Committee on Food which concluded that Bt11 sweet maize is as safe for human food use as conventional sweet maize.

The FSAI is the competent authority in Ireland for the legislation governing GM food. It does not give blanket approval to GM foods but individually evaluates, on its own merits, each application to place a new GM food on the EU market. The FSAI is satisfied that based on the best scientific evidence available, all of the GM foods and ingredients currently on the EU market are as safe as those derived from their non-GM counterparts.

The authorisation of Bt11 follows upon the introduction in November 2003, of Regulation (EC) No 1829/2003 on GM Food and Feed which replaces the GM part of the Novel Food Regulation (EC) No 258/97, and heralded the completion of the new tranche of EU legislation in the area of GMOs. The objective of this regulation, in accordance with the general principles laid down in European food safety legislation, is to provide the basis for ensuring a high level of protection of human life and health, animal health and welfare, environment and consumer interests in relation to GM food and feed, while ensuring the effective functioning of the internal market. Also introduced at that time was Regulation (EC) No 1830/2003 on traceability and labelling of GMOs and traceability of food and feed produced from GMOs. The objective of this regulation is to provide for an improved labelling and traceability framework for GM-food and GM-feed and came into effect in April 2004. It aims to respond to citizens' demands for more and better information on GMOs, and the need to facilitate the freedom of choice between new and more traditional food products. There are eight current applications for authorisation of GM foods. It is expected that of these eight, only maize lines NK603, GA21 and MON 863 will follow the approvals procedure under Regulation (EC) No. 258/97. Any future applications will follow the approvals procedure set out under Regulation (EC) No. 1829/2003.

Barr
Roinn